BRIEF published on 06/06/2024 at 08:05, 2 years 4 months ago Aquis Stock Exchange: Suspension of Trading Securities Aquis Stock Exchange Suspension Of Trading ChallengerX
BRIEF published on 06/06/2024 at 08:05, 2 years 4 months ago Bourse Aquis : Suspension des cotations Titres Bourse Aquis Suspension Des Négociations ChallengerX
BRIEF published on 06/06/2024 at 08:05, 2 years 4 months ago Defence Therapeutics' AccuTOX Study Published in Journal of Translational Medicine Clinical Trials Immunotherapy Defence Therapeutics AccuTOX Anti-cancer
BRIEF published on 06/06/2024 at 08:05, 2 years 4 months ago L'étude AccuTOX de Defense Therapeutics publiée dans le Journal of Translational Medicine Immunothérapie Essais Cliniques Thérapeutique De Défense AccuTOX Anti-cancer
BRIEF published on 06/06/2024 at 08:05, 2 years 4 months ago OL Vallée Arena cédée à Holnest et un groupe d'investisseurs Eagle Football Group OL Vallée Arena LDLC Arena Holnest Jean-Michel Aulas
BRIEF published on 06/06/2024 at 08:05, 2 years 4 months ago OL Vallée Arena sold to Holnest and a group of investors Eagle Football Group OL Vallée Arena LDLC Arena Holnest Jean-Michel Aulas
BRIEF published on 06/06/2024 at 07:35, 2 years 4 months ago Theranexus et BBDF annoncent des résultats positifs à 18 mois pour Batten-1 dans une étude de phase 1/2 Theranexus Batten-1 Maladie De Batten BBDF Neurofilaments
BRIEF published on 06/06/2024 at 07:35, 2 years 4 months ago Theranexus and BBDF Announce Positive Results at 18 Months for Batten-1 in Phase 1/2 Study Theranexus Batten-1 BBDF Batten Disease Neurofilaments
BRIEF published on 06/06/2024 at 07:35, 2 years 4 months ago Remy Cointreau Announces Financial Results Financial Results Revenue Growth Net Income Market Performance Strategic Direction
BRIEF published on 06/06/2024 at 07:35, 2 years 4 months ago Rémy Cointreau annonce ses résultats financiers Résultats Financiers Hausse Des Revenus Performance Du Marché Direction Stratégique Revenu Net
Published on 11/04/2026 at 23:10, 2 hours 47 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 2 hours 57 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 3 hours 42 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 3 hours 52 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 00:02, 1 hour 54 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 6 hours 15 minutes ago EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 6 hours 31 minutes ago Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:43, 7 hours 14 minutes ago EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Published on 11/04/2026 at 18:05, 7 hours 51 minutes ago Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production
Published on 11/04/2026 at 18:00, 7 hours 56 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 7 hours 56 minutes ago L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:44, 8 hours 13 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
